Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01888185 · ClinicalTrials.gov registry record

Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)

A clinical trial, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
290
Enrollment target

NCT01888185 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 290 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01888185 has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
290 participants
Enrollment target

Study Summary

This study is designed to determine if magnetic resonance imaging (MRI) measures can be used to diagnose and monitor the progression of Parkinson's disease (PD) while distinguishing between PD and parkinsonisms \[conditions that are PD look-a-like diseases such as progressive supranuclear palsy (PSP) or multiple system atrophy (MSA)\] when combined with changes in certain proteins in body fluids that are related to iron (Fe).

Trial Details

FieldValue
Enrollment Target 290 participants
Start Date 2012-12
Est. Completion 2019-12-31

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT01888185

The ClinicalTrials.gov registry entry for NCT01888185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01888185 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01888185 about?

NCT01888185 is a clinical study titled "Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)". This study is designed to determine if magnetic resonance imaging (MRI) measures can be used to diagnose and monitor the progression of Parkinson's disease (PD) while distinguishing between PD and parkinsonisms \[conditions that are PD look-a-like diseases such as progressive supranuclear palsy (PSP...

What is the current status of trial NCT01888185?

This trial is currently completed. The enrollment target is 290 participants. The study started on 2012-12. Estimated completion is 2019-12-31.

Who is sponsoring clinical trial NCT01888185?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.